Trial Profile
Evaluation of Incidence of Non Adherence to Treatment With Once-daily Formulation of Tacrolimus (ADVAGRAF) in Kidney Transplant Recipients
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 10 Jul 2016 Planned End Date changed from 1 Jul 2018 to 1 Aug 2018.
- 10 Jul 2016 Planned primary completion date changed from 1 Jul 2018 to 1 Aug 2018.
- 10 Jul 2016 Planned initiation date changed from 1 Jul 2016 to 1 Aug 2016.